Effects of endocrine disruptors on dehydroepiandrosterone sulfotransferase and enzymes involved in PAPS synthesis: Genomic and nongenomic pathways

Environmental Health Perspectives

Volumn 115, Issue SUPPL1, 2007, Pages 51-54

  Harris, Robert ^a   Turan, Nahid ^a   Kirk, Christopher ^a   Ramsden, David ^a   Waring, Rosemary ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

DHEA; Endocrine disruptor; Nongenomic; PAPS; Plasticizers; Sulfotransferase

Indexed keywords

4 OCTYLPHENOL; 4-OCTYLPHENOL; ADENOSINE 3' PHOSPHATE 5' PHOSPHOSULFATE; CYSTEINE DIOXYGENASE; ENDOCRINE DISRUPTOR; MESSENGER RNA; MULTIENZYME COMPLEX; PAPS SYNTHETASE; PHENOL DERIVATIVE; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PHTHALIC ACID DERIVATIVE; PHTHALIC ACID DIISODECYL ESTER; PLASTICIZER; PRASTERONE SULFOTRANSFERASE; SULFATE ADENYLYLTRANSFERASE; SULFITE OXIDASE; SULFOTRANSFERASE; UNCLASSIFIED DRUG;

ARTICLE; DOSE RESPONSE; DRUG EFFECT; HUMAN; MEDULLOBLASTOMA; METABOLISM; POLLUTANT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

CELL LINE, TUMOR; CYSTEINE DIOXYGENASE; DIETHYLHEXYL PHTHALATE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCRINE DISRUPTORS; ENVIRONMENTAL POLLUTANTS; HUMANS; MEDULLOBLASTOMA; MULTIENZYME COMPLEXES; PHENOLS; PHOSPHOADENOSINE PHOSPHOSULFATE; PHTHALIC ACIDS; PLASTICIZERS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SULFATE ADENYLYLTRANSFERASE; SULFITE OXIDASE; SULFOTRANSFERASES;

EID: 40949152520     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.9365     Document Type: Article

References (34)

1. Amaral Mendes JJ. 2002. The endocrine disrupters: a major medical challenge. Food Chem Toxicol 40:781-788.
2. Armanini D, Vecchio F, Basso A, Milone FF, Simoncini M, Fiore C, et al. 2003. Alzheimer's disease: pathophysiological implications of measurement of plasma cortisol, plasma DHEAS and lymphocytic corticosteroid receptors. Endocrine 22:113-118.
3. Baker VA. 2001. Endocrine disrupters - testing strategies to assess human hazard. Toxicol In Vitro 15:413-419.
4. Bonefeld-Jørgensen EC, Long M, Hofmeister MV, Vinggaard AM. 2007. Endocrine disrupting potentials of bisphenol A, bisphenol A dimethacrylate, 4-n-nonylphenol and 4-n-octylphenol in vitro: new data and a brief review. Environ Health Perspect 115(suppl 1):69-76.
5. Carr R, Bertasi F, Betancourt A, Bowers S, Gandy BS, Ryan P, et al. 2003. Effect of neonatal rat bisphenol A exposure on performance in the Morris water maze. J Toxicol Environ Health A 66:2077-2088.
6. Chang HJ, Zhou M, Lin SX. 2001. Human dehydroepiandrosterone sulfotransferase: purification and characterization of a recombinant protein. J Steroid Biochem Mol Biol 77:159-165.
7. Chen L, Miyamoto Y, Furuya K, Dai XN, Mori N, Sokabe M. 2006. Chronic DHEAS administration facilitates hippocampal longterm potentiation via an amplification of Src-dependent NMDA receptor signaling. Neuropharmacology 51:659-670.
8. Colborn T, Dumanoski D, Myers JP. 1996. Our Stolen Future: Are We Threatening Our Fertility, Intelligence, and Survival? A Scientific Detective Story. New York:Penguin Books Cornish-Bowden A. 2004. Fundamentals of enzyme kinetics. 3rd ed. London:Portland Press Ltd.
9. Do KQ, Tappaz ML. 1996. Specificity of cysteine sulfinate decarboxylase (CSD) for sulfur-containing amino acids. Neurochem Int 28:363-371.
10. Dubrovsky BO. 2005. Steroids, neuroactive steroids and neurosteroids in psycopathology. Prog Neuropsychopharmacol Biol Psychiatry 29:169-192.
11. Falany JL, Macrina N, Falany CN. 2002. Regulation of MCF-7 breast cancer cell growth by beta-estradiol sulfation. Breast Cancer Res Treat 74:167-176.
12. Fonnum F, Mariussen E, Reistad T. 2006. Molecular mechanisms involved in the toxic effects of polychlorinated biphenyls (PCBs) and brominated flame retardants (BFRs). J Toxicol Environ Health A 69:21-35.
13. GenBank. 2006. GenBank Overview. Available: http://www.ncbi.nlm.nih.gov/Genbank/index.html [accessed 10 October 2005].
14. Griffith OW. 1987. Mammalian sulfur amino acid metabolism: an overview. Methods Enzymol 143:366-376.
15. Guenther K, Heinke V, Thiele B, Kleist E, Prast H, Raecker T. 2002. Endocrine disrupting nonylphenols are ubiquitous in food. Environ Sci Technol 36:1676-1680.
16. Harris RM, Wood DM, Bottomley L, Blagg S, Owen K, Hughes PJ, et al. 2004. Phytoestrogens are potent inhibitors of estrogen sulfation: implications for breast cancer risk and treatment. J Clin Endocrinol Metab 89:1779-1787.
17. Heuser I, Deuschle M, Luppa P, Schweiger U, Standhardt H, Weber B. 1998. Increased diurnal plasma concentrations of dehydroepiandrosterone in depressed patients. J Clin Endocrinol Metab 83:3130-3133.
18. Jobling S, Reynolds T, White R, Parker MG, Sumpter JP. 1995. A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly oestrogenic. Environ Health Perspect 103:582-587.
19. Kawato S. 2004. Endocrine disrupters as disrupters of brain function: a neurosteroid viewpoint. Environ Sci 11:1-14.
20. Kirk CJ, Bottomley L, Minican N, Carpenter H, Shaw S, Kohli N, et al. 2003. Environmental endocrine disrupters dysregulate estrogen metabolism and Ca2+ homeostasis in fish and mammals via receptor-independent mechanisms. Comp Biochem Physiol A Mol Integr Physiol 135:1-8.
21. Kirk CJ, Harris RM, Wood DM, Waring RH, Hughes PJ. 2001. Do dietary phytoestrogens influence susceptibility to hormonedependent cancer by disrupting the metabolism of endogenous oestrogens? Biochem Soc Trans 29:209-216.
22. MacLusky NJ, Hajszan T, Leranth C. 2005. The environmental estrogen bisphenol A inhibits estradiol-induced hippocampal synaptogenesis. Environ Health Perspect 113:675-679.
23. Mayo W, George O, Darbra S, Bouyer J-J, Vallée M, Darnaudéry M, et al. 2003. Individual differences in cognitive aging: implication of pregnenolone sulfate. Prog Neurobiol 71:43-48.
24. Pernas-Alonso R, Morelli F, di Porzio U, Perrone-Capano C. 1999. Multiplex semi-quantitative reverse transcriptase-polymerase chain reaction of low abundance neuronal mRNAs. Brain Res Brain Res Protoc 4:395-406.
25. Qian Y, Deng C, Song WC. 1998. Expression of estrogen sulfotransferase in MCF-7 cells by cDNA transfection suppresses the estrogen response: potential role of the enzyme in regulating estrogen-dependent growth of breast epithelial cells. J Pharmacol Exp Ther 286:555-560.
26. Racchi M, Balduzzi C, Corsini E. 2003. Dehydroepiandrosterone (DHEA) and the aging brain: flipping a coin in the "fountain of youth." CNS Drug Rev 9:21-40.
27. Ravaglia G, Forti P, Maioli F, Boschi F, Bernardi M, Pratelli L, et al. 1996. The relationship of dehydroepiandrosterone sulfate (DHEAS) to endocrine-metabolic parameters and functional status in the oldest-old. Results from an Italian study on healthy free-living over-ninety-year-olds. J Clin Endocrinol Metab 81:1173-1178.
28. Tapiero H, Ba GN, Tew KD. 2002. Estrogens and environmental estrogens. Biomed Pharmacother 56:36-44.
29. Toppari J, Larsen JC, Chistiansen P, Giwercman A, Grandjean P, Guillette LJ, et al. 1996. Male reproductive health and environmental xenooestrogens. Environ Health Perspect 104(suppl 4):741-803.
30. Vallée M, Mayo W, Le Moal M. 2001. Role of pregnenolone, dehydroepiandrosterone and their sulfate esters on learning and memory in cognitive aging. Brain Res Brain Res Rev 37:301-312.
31. Van der Oost R, Beyer J, Vermeulen NPE. 2003. Fish bioaccumulation and biomarkers in environmental risk assessment: a review. Env Toxicol Pharmacol. 13:57-149.
32. Waterhouse RN. 2003. Determination of lipophilicity and its use as a predictor of blood-brain barrier penetration of molecular imaging agents. Mol Imaging Biol. 5:376-389.
33. Weir HK, Marrett LD, Kreiger N, Darlington GA, Sugar L. 2000. Pre-natal and peri-natal exposures and risk of testicular germ-cell cancer. Int J Cancer 87:438-443.
34. Winer J, Jung CKS, Shackel I, Williams PM. 1999. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 270:41-49.